Fennec Pharmaceuticals (FENC) Total Liabilities (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Total Liabilities came in at $35.1 million in Q4 2025, down 30.97% YoY from $50.8 million in Q4 2024, and down 34.74% on a QoQ basis from $53.8 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Total Liabilities (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Total Liabilities data on file, last reported at $35.1 million in Q4 2025.
- Quarterly Total Liabilities fell 30.97% year-over-year to $35.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $35.1 million (down 30.97% YoY) and the FY2025 annual result came in at $35.1 million, down 30.97% from the prior year.
- Total Liabilities slipped to $35.1 million in Q4 2025, from $53.8 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $66.2 million in Q1 2024 to a low of $5.8 million in Q2 2021.
- A 5-year average of $34.2 million and a median of $29.5 million in 2022 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2021 — Total Liabilities sank 85.16% — and 2022, when it jumped 344.26%.
- Tracing FENC's Total Liabilities over 5 years: stood at $6.6 million in 2021, then surged by 344.26% to $29.5 million in 2022, then surged by 30.43% to $38.5 million in 2023, then jumped by 32.04% to $50.8 million in 2024, then tumbled by 30.97% to $35.1 million in 2025.
- The last three Total Liabilities figures came in at $35.1 million (Q4 2025), $53.8 million (Q3 2025), and $52.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | 33.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.31 Mn |
| Dec 31, 2025 | 35.08 Mn |
| Sep 30, 2025 | 53.75 Mn |
| Jun 30, 2025 | 52.34 Mn |
| Mar 31, 2025 | 52.28 Mn |
| Dec 31, 2024 | 50.82 Mn |
| Sep 30, 2024 | 64.09 Mn |
| Jun 30, 2024 | 64.52 Mn |
| Mar 31, 2024 | 66.18 Mn |
| Dec 31, 2023 | 38.49 Mn |
| Sep 30, 2023 | 29.56 Mn |
| Jun 30, 2023 | 29.16 Mn |
| Mar 31, 2023 | 29.16 Mn |
| Dec 31, 2022 | 29.51 Mn |
| Sep 30, 2022 | 27.62 Mn |
| Jun 30, 2022 | 7.03 Mn |
| Mar 31, 2022 | 6.63 Mn |
| Dec 31, 2021 | 6.64 Mn |
| Sep 30, 2021 | 7.00 Mn |
| Jun 30, 2021 | 5.83 Mn |